Jane Street’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Jane Street’s Portfolio RVLP Stock Details RVLP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,103	Closed	-$6.22K	–	9648
2023 Q2	$6.22K	Sell	11,103 -6,682	-38%	-$5.89K	﹤0.01%	8481
2023 Q1	$20.3K	Buy	+17,785	New	+$21.3K	﹤0.01%	8642
2021 Q3	–	Sell	-35,028	Closed	-$105K	–	11010
2021 Q2	$105K	Buy	+35,028	New	+$107K	﹤0.01%	9241
2021 Q1	–	Sell	-10,144	Closed	-$42K	–	9741
2020 Q4	$42K	Buy	+10,144	New	+$58.5K	﹤0.01%	7337

Other funds holding RVLP

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

TAM

Titleist Asset Management San Antonio, Texas $1.49B AUM 22.27% 1-Year Est. Return

Jane Street's RVLP Position: Q3 2023 in Review

Jane Street sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2023, closing a stake of 11,103 shares — an estimated $6.22K sold.

Jane Street first reported a position in RVLP in Q4 2020 and held it in 4 quarters. The position peaked at $105K in Q2 2021. 32 funds tracked by Wall St. Rank hold RVLP as of Q3 2023.

Jane Street reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Jane Street sold 11,103 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2023, an estimated $6.22K.
Jane Street first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2020 and held it in 4 quarters.
Jane Street's RVL Pharmaceuticals plc Ordinary Shares position peaked at $105K in Q2 2021.
32 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.